Effectiveness of Flash Mediation Therapy

November 29, 2017 updated by: Hospices Civils de Lyon

Study on Effectiveness of Flash Mediation Therapy in the Context of Acute Psychological and Behavioral Symptoms of Dementia in Nursing Homes

In order to offer a non-drug intervention for caregivers in nursing home to respond promptly to a behavioral crisis with an appropriate response to each patient, a chariot has been developed by the Institute of Ageing Well Korian (Institut du Bien Vieillir Korian) to bring together eleven mediation activities. These activities lasting about 15 minutes are based on emotion (reminiscent, games) and sensory interventions (music, massage, touch) to decentralize patient stimulus that disturbs and focus on a subject not disruptive. This emergency intervention should provide a reduction in Behavioral and Psychological Symptom of Dementia (BPSD) of nursing home patients. The main objective is to measure its immediate effect on productive symptoms (agitation, aberrant motor behavior and disinhibition). The secondary objectives are to measure its immediate impact on the well-being and psychotropic treatments, and measure its effect after two months and after four months on all BPSD with a focus on agitation, the administration of psychotropic drugs, the hospitalizations and the number of falls.

Study Overview

Study Type

Interventional

Enrollment (Actual)

241

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lyon, France
        • Hôpital des Charpennes Centre de Recherche Clinique "Vieillissement-Cerveau-Fragilité"

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

58 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • People ability to object and does not oppose either by themselves or through a trusted person referred to in Article L. 1111-6 of the Code of Public Health, failing thereof, by the family, or, if a person talking to the person close and stable ties. For adults under guardianship, permission must be given by the legal representative of the person. The research will benefit from the backing of Persons Protection Committee (PPC) prior to its implementation;
  • Man or woman over 60 years;
  • patient living in one of the nursing homes participating in the project;
  • Patient completing the diagnostic criteria for major neurocognitive disorder according to Diagnostic and Statistical Manual of Mental Disorders V criteria (DSM-V)
  • The patient must have at least one of these productive symptoms (agitation, aberrant motor behavior, disinhibition) listed by the NPI-NH (score> 2 at least one of these items)

Exclusion Criteria:

  • Deafness or blindness may compromise patient assessment or participation in the intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 2 months control condition - 4 months chariot-flash
200 patient , in 15 nursing homes randomly will be exposed two months in the control condition (usual intervention) and 4 months in the experimental condition (chariot-flash intervention). The experimental condition is to propose the "chariot-flash" in emergency during the emergence or increase of productive symptoms.

The control condition is to propose the usual procedures for the management of productive symptoms during the emergence or increase of these symptoms.

The "chariot-flash" condition is a chariot with eleven drawers. Each drawer contains an activity (lasting about 15 minutes):

  • Boards of known photographs to recall autobiographical memories
  • Newspapers to read, talk, associate memories around an article
  • Massage Oil, refreshing wipes, cream to reconnect with the body
  • Clay, cookie pieces, washable felt and paper to create shapes, draw.
  • Walk with a person of the healthcare team the case of behavioral disorders in type of ambulation and untimely exit .
  • Listening to music
  • Relaxation-Breathing
  • Cushion, foam balls to vent his energy on secure hardware.
  • Plush doll or to invest a vector object of affection and empathy
  • Sensory flash balls that the patient can squeeze, throw, roll.
  • Games with which the patient can play according to its possibilities.
Experimental: 4 months control condition-2 months chariot flash
200 patient, in 14 other nursing homes will be exposed 4 months in the control condition and 2 months in the experimental condition

The control condition is to propose the usual procedures for the management of productive symptoms during the emergence or increase of these symptoms.

The "chariot-flash" condition is a chariot with eleven drawers. Each drawer contains an activity (lasting about 15 minutes):

  • Boards of known photographs to recall autobiographical memories
  • Newspapers to read, talk, associate memories around an article
  • Massage Oil, refreshing wipes, cream to reconnect with the body
  • Clay, cookie pieces, washable felt and paper to create shapes, draw.
  • Walk with a person of the healthcare team the case of behavioral disorders in type of ambulation and untimely exit .
  • Listening to music
  • Relaxation-Breathing
  • Cushion, foam balls to vent his energy on secure hardware.
  • Plush doll or to invest a vector object of affection and empathy
  • Sensory flash balls that the patient can squeeze, throw, roll.
  • Games with which the patient can play according to its possibilities.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in number of disorders
Time Frame: until 4 months

the number of disorders are evaluated with Cohen Mansfield Agitation Inventory (CMAI) before and 30 minutes after each intervention.

The original version of the CMAI is initially planned to study the frequency of these disorders. However, the goal being to study the decrease in productive symptoms, after using the "chariot-flash", only the number of this item will be considered (between 0 and 29). For example in this modified version, for the item "pace, aimless wandering" nursing team can answer "present" or "absent" instead of (never, less than once a week, once or twice per week, a few times over week, one to two times daily, several times a day, several times per hour)

until 4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in score of well-being
Time Frame: until 4 months

the score of well-being is assessed using the Instant Well-Being scale (Evaluation Instantané du Bien-Etre : EVIBE) before and 30 minutes after each intervention .

The EVIBE is a visual analogue scale for reporting the status of well-being of the patient at a specific time. On a graduated scale from 0 to 5, the caregiver should position a cursor position to the left corresponding to the feeling of well-being the lowest and the right position to the feeling of well-being the highest.

until 4 months
change in psychotropic drugs prescribed
Time Frame: until 4 months
The caregiver or doctor will check on a board what are the treatments that have been added or modified (compared to the usual treatment) in response to behavioral disorder
until 4 months
change in score of BPSD
Time Frame: before the beginning of the study, at 2 months, 4 months and 6 months

the score of BPSD is assessed using the neuropsychiatric inventory nursing home version (NPI-NH).

Each of the 12 BPSD (delusions, hallucinations, agitation, depression, anxiety, excitement, apathy, disinhibition, depression, motor aberrant behavior, sleep and appetite) is evaluated on 12 depending on its frequency and severity (global score =144).

before the beginning of the study, at 2 months, 4 months and 6 months
change in level of agitation
Time Frame: before the beginning of the study, at 2 months, 4 months and 6 months
the level of agitation is assessed using the original version of CMAI. The CMAI lists 29 agitation and aggressive behaviors by frequency (0: not evaluable 1: never, 2: less than once a week 3 : once or twice per week, 4 : a few times over week, 5: one to two times daily, 6 : several times a day, 7 : several times per hour) to obtain a score ranging from 0-203.
before the beginning of the study, at 2 months, 4 months and 6 months
change in the number of administered psychotropic drugs.
Time Frame: before the beginning of the study, at 2 months, 4 months and 6 months
The caregiver or doctor will check on a board on which is written all psychotropic treatments that the patient takes and the dosage
before the beginning of the study, at 2 months, 4 months and 6 months
The number of hospitalization
Time Frame: at 2 months, 4 months and 6 months
The caregiver or doctor will refer in a table the different hospitalizations during the study and their date
at 2 months, 4 months and 6 months
The number of fall
Time Frame: at 2 months, 4 months and 6 months
The caregiver or doctor will refer in a table the different falls during the study and their date.
at 2 months, 4 months and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Pierre Krolak Salmon, Hospices Civils de Lyon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (Actual)

March 1, 2017

Study Completion (Actual)

March 1, 2017

Study Registration Dates

First Submitted

October 12, 2016

First Submitted That Met QC Criteria

October 12, 2016

First Posted (Estimate)

October 14, 2016

Study Record Updates

Last Update Posted (Actual)

December 2, 2017

Last Update Submitted That Met QC Criteria

November 29, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on 2 months control condition - 4 months chariot-flash

3
Subscribe